Shypd.aiThe largest open index of AI tools.png&w=3840&q=75){kind=small}
Lir Therapeutics is an AI-powered gene therapy tool that engineers viral vectors to improve dose reduction, precision targeting, and immune evasion. It utilizes the nAAVigator® platform for advanced viral design.
Trending
About
Lir Therapeutics is at the forefront of gene therapy, leveraging an AI-first approach to reprogram viral vectors. The company's core mission is to overcome key challenges in gene therapy, focusing on dose reduction, precision targeting, and immune evasion. By improving the efficiency of viral vectors, Lir aims to reduce toxicity risks and lower the cost of gene therapies. Their nAAVigator® platform is a holistic viral design engine trained on unique datasets, engineered to model viral vectors at all levels for simultaneous safety and efficacy. This platform integrates immunogenicity landscape models, physics-based structural models, functional protein models, and viral DNA foundation models. Lir operates an integrated lab-in-the-loop, generating high-throughput data to drive its AI models and design precise experiments for advanced viral vector engineering.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check lirtx.com for current pricing.
FAQs
Trending
